To what extent is it right to measure serum vaspin, obestatin, and apelin-36 levels without a protease inhibitor in nonalcoholic fatty liver disease?
| dc.contributor.author | Aydin, Suleyman | |
| dc.contributor.author | Sahin, Ibrahim | |
| dc.contributor.author | Demirel, Ulvi | |
| dc.contributor.author | Aksoy, Aziz | |
| dc.date.accessioned | 2026-08-12T16:13:42Z | |
| dc.date.issued | 2011 | |
| dc.department | Fırat Üniversitesi | |
| dc.description.abstract | [Abstract Not Available] | |
| dc.identifier.doi | 10.1016/j.metabol.2011.01.015 | |
| dc.identifier.issn | 1532-8600 | |
| dc.identifier.issue | 7 | |
| dc.identifier.pmid | 21397283 | |
| dc.identifier.scopus | 2-s2.0-79959357939 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.startpage | E1 | |
| dc.identifier.uri | https://doi.org/10.1016/j.metabol.2011.01.015 | |
| dc.identifier.uri | https://hdl.handle.net/11508/43182 | |
| dc.identifier.volume | 60 | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.relation.ispartof | Metabolism: Clinical and Experimental | |
| dc.relation.publicationcategory | Diğer | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.snmz | KA_Scopus_20260511 | |
| dc.subject | Fatty Liver; Ghrelin; Humans; Intercellular Signaling Peptides and Proteins; Protease Inhibitors; Serpins; amino acid; apelin; apelin 36; aprotinin; benzylsulfonyl fluoride; caspase; gamma glutamyltransferase; kallikrein inhibitor; obestatin; proteinase inhibitor; unclassified drug; vaspin; apoptosis; biochemistry; blood analysis; disease course; gamma glutamyl transferase blood level; gastrointestinal tract; hormone blood level; human; letter; liver cirrhosis; nonalcoholic fatty liver; priority journal; protein degradation; tube | |
| dc.title | To what extent is it right to measure serum vaspin, obestatin, and apelin-36 levels without a protease inhibitor in nonalcoholic fatty liver disease? | |
| dc.type | Letter |
